Comment: Comparison of FDA reports of patient deaths associated with sildenafil and injectable alprostadil [3]

Annals of Pharmacotherapy

Volumn 35, Issue 9, 2001, Pages 1143-

  Strom, Brian L ^a   Cohen, Jay S ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTAGLANDIN E1; SILDENAFIL;

CARDIOVASCULAR DISEASE; DEATH; ERECTILE DYSFUNCTION; FOOD AND DRUG ADMINISTRATION; HUMAN; LETTER; PRIORITY JOURNAL;

ADVERSE DRUG REACTION REPORTING SYSTEMS; ALPROSTADIL; HUMANS; MALE; MORTALITY; PHOSPHODIESTERASE INHIBITORS; PIPERAZINES; REPRODUCIBILITY OF RESULTS; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION; VASODILATOR AGENTS;

EID: 0034829144     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1177/106002800103500907     Document Type: Letter

References (0)